查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1530758

2030 年维生素 K2 市场预测：按产品类型、成分、形式、分销管道、应用和地区进行的全球分析

Vitamin K2 Market Forecasts to 2030 - Global Analysis By Product Type, Source, Form, Distribution Channel, Application and Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2024 年全球维生素 K2 市场规模为 1.596 亿美元，预计到 2030 年将达到 5.747 亿美元，预测期内复合年增长率为 23.8%。

维生素K2是血液凝固和骨骼代谢所必需的脂溶性维生素。它在激活调节钙分布的蛋白质、引导钙到达骨骼和牙齿以及防止动脉钙化方面发挥重要作用。 K2 支持心血管健康、骨骼强度和牙齿健康。它存在于发酵食品和动物食品中，也作为补充品出售。随着人们健康意识的增强，它越来越受欢迎，因为它预计会对认知功能和胰岛素敏感性产生影响。

健康意识不断增强

随着消费者越来越重视预防保健和营养食品，健康意识的提高正在推动维生素 K2 市场的发展。维生素 K2 因其在骨骼健康、心血管健康和其他生理功能方面的潜在作用而受到认可。注重健康的人们对维生素 K2 益处的认识不断提高，积极主动的医疗保健倡议正在促进市场成长，并推动对含有维生素 K2 的补充品和强化食品的需求。

消费者意识有限

儘管人们对维生素 K2 的兴趣日益浓厚，但消费者对维生素 K2 的认识较低是市场成长的主要阻碍因素。许多人不熟悉维生素 K2 的具体益处以及它与维生素 K1 的差异。这种知识的缺乏可能会导致在购买维生素 K2 产品时感到困惑和犹豫。此外，医疗保健专业人员也不熟悉维生素 K2补充品，可能不会持续推荐补充品。

高龄化社会

感测器技术的进步为维生素 K2 市场创造了重大机会。无线感测网路和先进的 pH、浊度和溶解氧氧气感测器等创新提高了维生素 K2 的准确性和效率。这些进步实现了即时资料收集和分析，改善污染检测和水质管理，并推动市场成长。

与其他维生素的竞争

来自其他维生素的竞争对维生素 K2 市场构成了重大威胁。在骨骼健康方面，维生素 D 和钙等众所周知的维生素往往被维生素 K2 所掩盖。消费者可能会优先考虑这些熟悉的营养素而不是维生素 K2。此外，声称可提供全面营养支持的综合维他命製剂可能会减少对单一维生素 K2补充品的需求。

COVID-19 的影响：

COVID-19 大流行最初透过供应链中断和产量减少扰乱了维生素 K2 市场。然而，大流行增加了消费者对预防性健康措施和免疫支持的兴趣。因此，人们对维生素和含有维生素 K2的补充品的兴趣增加。此次疫情凸显了整体健康和营养的重要性，并且由于消费者优先考虑健康，因此可能会推动维生素 K2 市场的长期成长。

MK-7 预计将在预测期内成为最大的细分市场

与其他形式相比，MK-7 凭藉卓越的生物利用度和较长的半衰期，预计将主导维生素 K2 市场。 MK-7 在体内保持活性较长时间，提供持久的效果。 MK-7 在低剂量下即可发挥作用，使其作为补充品配方颇具吸引力。越来越多的研究支持 MK-7 对骨骼和心血管健康的功效，这也有助于巩固 MK-7 市场的主导地位。由于 MK-7 的有效性已得到证实，消费者和製造商越来越青睐它，从而推动了市场占有率的成长。

预计合成材料领域在预测期内复合年增长率最高

由于多种因素，预计合成维生素 K2 细分市场的成长率最高。与天然维生素 K2 相比，合成维生素 K2 生产方法可提供一致的品质、扩充性和成本效益。这使得製造商能够满足不断增长的需求，同时保持产品稳定性。合成维生素K2可以全年生产，不受天然来源的限制。生产技术的进步提高了合成维生素 K2 的纯度和生物利用度，使其越来越能与天然维生素 K2 相提并论。这些因素促进了合成维生素 K2 的快速成长。

占比最大的地区：

由于多种因素，亚太地区有望主导维生素 K2 市场。该地区人口众多，健康意识不断提高，增加了对营养食品的需求。日本等国家透过纳豆等传统食品摄取维生素 K2 有着悠久的历史。在中国和印度等国家，可支配收入的增加和都市化正在推动健康产业的发展。主要维生素 K2 製造商在该地区的存在，加上强大的食品市场，有助于在亚太地区保持市场领先地位。此外，政府促进预防性医疗保健的措施也支持市场成长。

复合年增长率最高的地区：

预计亚太地区将维持维生素 K2 市场的最高成长率。快速的都市化和生活方式的改变正在增加与生活方式相关的健康问题的发生率，从而推动了对预防性补充品的需求。该地区的人口老化，特别是日本和韩国等国家的人口老化，正在为骨骼和心血管保健产品创造一个不断增长的市场。加强消费者对营养和健康的教育正在提高维生素 K2 的认识。新兴经济体中阶的扩大和医疗保健支出的增加推动了该地区维生素 K2 市场的快速成长。

免费客製化服务：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二次研究资讯来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 应用分析
  • 新兴市场
  • COVID-19 的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球维生素 K2 市场：依产品类型

  • MK-4
  • MK-7
  • 其他产品类型

第六章全球维生素 K2 市场：依原料分类

  • 自然的
    • 纳豆（发酵大豆食品）
    • 起司
    • 蛋
    • 其他自然资源
  • 合成

第七章全球维生素 K2 市场：依形式

  • 粉末和结晶
  • 胶囊和锭剂
  • 油和液体

第八章全球维生素 K2 市场：依通路划分

  • 网路零售
  • 实体零售业
    • 药局
    • 专卖店
  • 医院/诊所

第九章全球维生素 K2 市场：依应用分类

  • 保健补充品
  • 药品
  • 功能性食品和饮料
  • 化妆品
  • 营养食品
  • 其他用途

第10章全球维生素K2市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第十一章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务拓展
  • 其他关键策略

第十二章 公司概况

  • Kappa Bioscience
  • Lesaffre
  • DSM Nutritional Products
  • NattoPharma
  • Kyowa Hakko Bio Co., Ltd.
  • Viridis BioPharma
  • Seebio Biotech（Shanghai）Co., Ltd.
  • Danisco A/S
  • Frutarom
  • Shandong Guangtongbao Pharmaceuticals Co., Ltd.
  • GeneFerm Biotechnology Co., Ltd.
  • Penglai Marine Bio-Tech Co., Ltd.
  • Herbonutra
  • J-Oil Mills, Inc.
  • Zhejiang Hisun Bio-Tech Co., Ltd.
  • Yihai Kerry Group
  • Huazhong Pharmaceutical Co., Ltd.
  • NattoPharma ASA
Product Code: SMRC26870

According to Stratistics MRC, the Global Vitamin K2 Market is accounted for $159.6 million in 2024 and is expected to reach $574.7 million by 2030 growing at a CAGR of 23.8% during the forecast period. Vitamin K2 is a fat-soluble vitamin essential for blood clotting and bone metabolism. It plays a crucial role in activating proteins that regulate calcium distribution, directing it to bones and teeth while preventing arterial calcification. K2 supports cardiovascular health, bone strength, and dental health. They are found in fermented foods and animal products and are also available as supplements. The potential benefits for cognitive function and insulin sensitivity make it increasingly popular in health-conscious circles.

Market Dynamics:

Driver:

Growing health consciousness

Growing health consciousness drives the vitamin K2 market as consumers increasingly prioritize preventive healthcare and nutritional supplements. Vitamin K2 is recognized for its role in bone health, cardiovascular health, and potentially in other physiological functions. Rising awareness about the benefits of Vitamin K2 among health-conscious individuals and proactive healthcare initiatives contribute to market growth, fostering demand for supplements and fortified foods containing Vitamin K2.

Restraint:

Limited consumer awareness

Despite growing interest, limited consumer awareness about vitamin K2 remains a significant restraint on market growth. Many people are unfamiliar with Vitamin K2's specific benefits and how it differs from Vitamin K1. This lack of knowledge can lead to confusion and hesitation when purchasing vitamin K2 products. Additionally, healthcare professionals may not consistently recommend vitamin K2 supplements due to limited familiarity.

Opportunity:

Aging population

Technological advancements in sensor technology present significant opportunities for the Vitamin K2 market. Innovations such as wireless sensor networks, advanced pH, turbidity, and dissolved oxygen sensors enhance the accuracy and efficiency of Vitamin K2. These advancements enable real-time data collection and analysis, improving contamination detection and water quality management, thus driving market growth.

Threat:

Competition from other vitamins

Competition from other vitamins poses a significant threat to the vitamin K2 market. More established and well-known vitamins like vitamin D and calcium often overshadow vitamin K2 in the bone health segment. Consumers may prioritize these familiar nutrients over vitamin K2. Additionally, multivitamin formulations that claim to provide comprehensive nutrition can reduce the perceived need for standalone vitamin K2 supplements.

Covid-19 Impact:

The COVID-19 pandemic initially disrupted the Vitamin K2 market through supply chain interruptions and reduced production. However, it also increased consumer focus on preventive health measures and immune support. This led to growing interest in vitamins and supplements, including Vitamin K2. The pandemic highlighted the importance of overall health and nutrition, potentially driving long-term growth in the Vitamin K2 market as consumers prioritize wellness.

The MK-7 segment is expected to be the largest during the forecast period

The MK-7 segment is anticipated to dominate the vitamin K2 market due to its superior bioavailability and longer half-life compared to other forms. MK-7 remains active in the body for a longer duration, providing sustained benefits. Its effectiveness in lower doses makes it attractive for supplement formulations. The growing body of research supporting MK-7's benefits for bone and cardiovascular health contributes to its market dominance. Consumers and manufacturers increasingly prefer the MK-7 for its proven efficacy, driving its larger market share.

The synthetic segment is expected to have the highest CAGR during the forecast period

The synthetic vitamin K2 segment is projected to experience the highest growth rate due to several factors. Synthetic production methods offer consistent quality, scalability, and cost-effectiveness compared to natural sources. This allows manufacturers to meet increasing demand while maintaining product stability. Synthetic vitamin K2 can be produced year-round, independent of natural source limitations. Advancements in production technologies are improving the purity and bioavailability of synthetic forms, making them increasingly comparable to natural sources. These factors contribute to the rapid growth of the synthetic segment.

Region with largest share:

Asia Pacific is poised to dominate the vitamin K2 market due to several factors. The region's large population and increasing health awareness drive demand for nutritional supplements. Countries like Japan have a long history of vitamin K2 consumption through traditional foods like natto. Growing disposable incomes and urbanization in countries like China and India are fueling the wellness industry. The presence of major vitamin K2 manufacturers in the region, coupled with a strong nutraceutical market, contributes to Asia Pacific's market leadership. Additionally, government initiatives promoting preventive healthcare support market growth.

Region with highest CAGR:

Asia Pacific is expected to maintain the highest growth rate in the vitamin K2 market. Rapid urbanization and changing lifestyles are increasing the prevalence of lifestyle-related health issues, driving demand for preventive supplements. The region's aging population, particularly in countries like Japan and South Korea, creates a growing market for bone and cardiovascular health products. Increasing consumer education about nutrition and wellness is boosting vitamin K2 awareness. The expanding middle class and rising healthcare expenditure in emerging economies contribute to the region's high growth rate in the vitamin K2 market.

Key players in the market

Some of the key players in Vitamin K2 market include Kappa Bioscience, Lesaffre, DSM Nutritional Products, NattoPharma, Kyowa Hakko Bio Co., Ltd., Viridis BioPharma, Seebio Biotech (Shanghai) Co., Ltd., Danisco A/S, Frutarom, Shandong Guangtongbao Pharmaceuticals Co., Ltd., GeneFerm Biotechnology Co., Ltd., Penglai Marine Bio-Tech Co., Ltd., Herbonutra, J-Oil Mills, Inc., Zhejiang Hisun Bio-Tech Co., Ltd., Yihai Kerry Group, Huazhong Pharmaceutical Co., Ltd. and NattoPharma ASA.

Key Developments:

In March 2024, Kyowa Hakko Bio, Co., Ltd. and Kyowa Hakko USA, Inc., a subsidiary of Kirin Holdings Co., has opened its expanded citicoline manufacturing facility at its Kyowa Hakko Bio Yamaguchi Production Center in Hofu City, Yamaguchi Prefecture, Japan. With the expanded facility, the Kirin Group is planning to integrate citicoline into upcoming product development initiatives, the company said. Kyowa Hakko Bio manufactures Cognizin, a citicoline brand, through a fermentation process for health food and pharmaceutical manufacturers.

In November 2023, Lesaffre is expanding its footprint in the United States through several capital investments and acquisitions. The company, which primarily focuses on yeast, bacteria and baking ingredients, is expanding into the nutrition, health and biotechnology sectors. With the expansion, the company is investing in both new equipment and R&D. Lesaffre has added a 10th fermentor for the Red Star Yeast, LLC yeast plant in Cedar Rapids, Iowa. At the same plant, the company also invested in a new dryer for its Phileo, Lesaffre business unit focused on animal nutrition and health customer demand, the company said.

In June 2022, Fermenta Biotech and Kappa Bioscience, a Norwegian entity, have announced a strategic partnership that positions Fermenta as the distributor of Kappa's K2VITAL MCT and MCC range of vitamin K2 for the Indian market. The collaboration combines Kappa's vitamin K2 manufacturing capabilities with Fermenta's distribution network and market expertise in India.

Product Types Covered:

  • MK-4
  • MK-7
  • Product Types

Sources Covered:

  • Natural
  • Synthetic

Forms Covered:

  • Powder and Crystalline
  • Capsules and Tablets
  • Oils and Liquid

Distribution Channels Covered:

  • Online Retail
  • Brick-and-Mortar Retail
  • Hospitals & Clinics

Applications Covered:

  • Health Supplements
  • Pharmaceuticals
  • Functional Food and Beverages
  • Cosmetics
  • Nutraceuticals
  • Other Applications

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Vitamin K2 Market, By Product Type

  • 5.1 Introduction
  • 5.2 MK-4
  • 5.3 MK-7
  • 5.4 Other Product Types

6 Global Vitamin K2 Market, By Source

  • 6.1 Introduction
  • 6.2 Natural
    • 6.2.1 Natto (Soybean Ferment)
    • 6.2.2 Cheese
    • 6.2.3 Eggs
    • 6.2.4 Other Natural Sources
  • 6.3 Synthetic

7 Global Vitamin K2 Market, By Form

  • 7.1 Introduction
  • 7.2 Powder and Crystalline
  • 7.3 Capsules and Tablets
  • 7.4 Oils and Liquid

8 Global Vitamin K2 Market, By Distribution Channel

  • 8.1 Introduction
  • 8.2 Online Retail
  • 8.3 Brick-and-Mortar Retail
    • 8.3.1 Pharmacies
    • 8.3.2 Specialty Stores
  • 8.4 Hospitals & Clinics

9 Global Vitamin K2 Market, By Application

  • 9.1 Introduction
  • 9.2 Health Supplements
  • 9.3 Pharmaceuticals
  • 9.4 Functional Food and Beverages
  • 9.5 Cosmetics
  • 9.6 Nutraceuticals
  • 9.7 Other Applications

10 Global Vitamin K2 Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Kappa Bioscience
  • 12.2 Lesaffre
  • 12.3 DSM Nutritional Products
  • 12.4 NattoPharma
  • 12.5 Kyowa Hakko Bio Co., Ltd.
  • 12.6 Viridis BioPharma
  • 12.7 Seebio Biotech (Shanghai) Co., Ltd.
  • 12.8 Danisco A/S
  • 12.9 Frutarom
  • 12.10 Shandong Guangtongbao Pharmaceuticals Co., Ltd.
  • 12.11 GeneFerm Biotechnology Co., Ltd.
  • 12.12 Penglai Marine Bio-Tech Co., Ltd.
  • 12.13 Herbonutra
  • 12.14 J-Oil Mills, Inc.
  • 12.15 Zhejiang Hisun Bio-Tech Co., Ltd.
  • 12.16 Yihai Kerry Group
  • 12.17 Huazhong Pharmaceutical Co., Ltd.
  • 12.18 NattoPharma ASA

List of Tables

  • Table 1 Global Vitamin K2 Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Vitamin K2 Market Outlook, By Product Type (2022-2030) ($MN)
  • Table 3 Global Vitamin K2 Market Outlook, By MK-4 (2022-2030) ($MN)
  • Table 4 Global Vitamin K2 Market Outlook, By MK-7 (2022-2030) ($MN)
  • Table 5 Global Vitamin K2 Market Outlook, By Other Product Types (2022-2030) ($MN)
  • Table 6 Global Vitamin K2 Market Outlook, By Source (2022-2030) ($MN)
  • Table 7 Global Vitamin K2 Market Outlook, By Natural (2022-2030) ($MN)
  • Table 8 Global Vitamin K2 Market Outlook, By Natto (Soybean Ferment) (2022-2030) ($MN)
  • Table 9 Global Vitamin K2 Market Outlook, By Cheese (2022-2030) ($MN)
  • Table 10 Global Vitamin K2 Market Outlook, By Eggs (2022-2030) ($MN)
  • Table 11 Global Vitamin K2 Market Outlook, By Other Natural Sources (2022-2030) ($MN)
  • Table 12 Global Vitamin K2 Market Outlook, By Synthetic (2022-2030) ($MN)
  • Table 13 Global Vitamin K2 Market Outlook, By Form (2022-2030) ($MN)
  • Table 14 Global Vitamin K2 Market Outlook, By Powder and Crystalline (2022-2030) ($MN)
  • Table 15 Global Vitamin K2 Market Outlook, By Capsules and Tablets (2022-2030) ($MN)
  • Table 16 Global Vitamin K2 Market Outlook, By Oils and Liquid (2022-2030) ($MN)
  • Table 17 Global Vitamin K2 Market Outlook, By Distribution Channel (2022-2030) ($MN)
  • Table 18 Global Vitamin K2 Market Outlook, By Online Retail (2022-2030) ($MN)
  • Table 19 Global Vitamin K2 Market Outlook, By Brick-and-Mortar Retail (2022-2030) ($MN)
  • Table 20 Global Vitamin K2 Market Outlook, By Pharmacies (2022-2030) ($MN)
  • Table 21 Global Vitamin K2 Market Outlook, By Specialty Stores (2022-2030) ($MN)
  • Table 22 Global Vitamin K2 Market Outlook, By Hospitals & Clinics (2022-2030) ($MN)
  • Table 23 Global Vitamin K2 Market Outlook, By Application (2022-2030) ($MN)
  • Table 24 Global Vitamin K2 Market Outlook, By Health Supplements (2022-2030) ($MN)
  • Table 25 Global Vitamin K2 Market Outlook, By Pharmaceuticals (2022-2030) ($MN)
  • Table 26 Global Vitamin K2 Market Outlook, By Functional Food and Beverages (2022-2030) ($MN)
  • Table 27 Global Vitamin K2 Market Outlook, By Cosmetics (2022-2030) ($MN)
  • Table 28 Global Vitamin K2 Market Outlook, By Nutraceuticals (2022-2030) ($MN)
  • Table 29 Global Vitamin K2 Market Outlook, By Other Applications (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.